Taipei, Nov. 20 (CNA) Taiwan's Food and Drug Administration (FDA) has ordered the recall of high blood pressure medication produced by Hsinchu County-based Genovate Biotechnology Co. after the drug was found to contain a carcinogenic substance.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Taiwan to welcome migrant workers from new partnering country: MOL
03/22/2023 09:03 PM - Business
Talent shortage top issue facing Taiwan chipmaking industry: Expert
03/22/2023 08:45 PM - Society
Taiwan seeks to remove parents' legal right to hit children
03/22/2023 07:30 PM - Politics
U.K. should help Taiwan's defense as much as possible: U.K. politician
03/22/2023 07:09 PM - Business
Taiwan shares soar almost 1.6% amid eased fears over U.S. bank woes
03/22/2023 06:40 PM